# FDA Inspection 1095336 - Osiris Therapeutics Inc - May 06, 2019

Source: https://www.keypedia.com/records/fda_inspections/osiris-therapeutics-inc/f09cc3a1-33db-4466-853e-349212a5a8fb
Source feed: FDA_Inspections

> FDA Inspection 1095336 for Osiris Therapeutics Inc on May 06, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095336
- Company Name: Osiris Therapeutics Inc
- Inspection Date: 2019-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1217534 - 2023-08-07](https://www.keypedia.com/records/fda_inspections/osiris-therapeutics-inc/8365a46d-90e7-44cf-8883-7c06233c45b3)
- [FDA Inspection 1095336 - 2019-05-06](https://www.keypedia.com/records/fda_inspections/osiris-therapeutics-inc/b42d067a-ce2c-4e48-a5e4-3e6f73798754)
- [FDA Inspection 967937 - 2016-04-07](https://www.keypedia.com/records/fda_inspections/osiris-therapeutics-inc/2f219695-1725-4a95-b6b5-8cee80af9b10)
- [FDA Inspection 834769 - 2013-06-04](https://www.keypedia.com/records/fda_inspections/osiris-therapeutics-inc/a0202a07-0abd-4cb7-b893-6c8a85397254)
- [FDA Inspection 736419 - 2011-07-14](https://www.keypedia.com/records/fda_inspections/osiris-therapeutics-inc/7df103a1-2211-42cf-aad3-321d3b9fd192)

Company: https://www.keypedia.com/companies/osiris-therapeutics-inc/6fee94f9-110a-4ce1-8f66-c4eb87626784

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d